Similarly, p53 and RAS are targets of GTPase activating protein (SH3 domain) binding protein 1 (G3BP1) [37], and shown to predict shorter survival in oesophageal cancer [38]. This evidence concerns the gene TP53 and carcinoma of esophagus.